Immunovant Inc.

15.77
-0.65 (-3.96%)
At close: Apr 03, 2025, 3:59 PM
15.69
-0.51%
After-hours: Apr 03, 2025, 06:23 PM EDT

Immunovant Cash Flow Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018
Period Ending Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018
-259.34M -210.96M -156.73M -107.43M -66.39M -28.6M -136.74M
231K 193K 126K 65K 21K 10K n/a
41.12M 32.3M 34.24M 18.82M 6.96M 1.31M 1.81M
1.41M 5.36M 10.52M 3.31M 3.84M -474K 1.44M
1.13M 1.13M 1.11M 933K 1.24M -792K 5.19M
n/a n/a n/a -282K n/a n/a n/a
2.63M -10.85M 15.14M 4.57M 4.81M -474K 1.44M
-214.23M -188.19M -106.11M -83.33M -53.36M -28.55M -128.3M
-360K -197K -254K -210K -31K -52K n/a
n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a
-360K -197K -254K -210K -31K -52K n/a
n/a n/a n/a n/a 37.91M n/a n/a
n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a
n/a 385K 200.13M 383.11M 109.07M 35.58M 128.3M
472.43M 70.89M 200.13M 383.11M 146.97M 35.58M 128.3M
258.83M -117.28M 93.67M 299.57M 93.59M 6.99M n/a
-214.59M -188.39M -106.37M -83.54M -53.39M -28.6M -128.3M